C-Peptide Levels Predict the Effectiveness of Dipeptidyl Peptidase-4 Inhibitor Therapy

Background. Our aim was to define the conditions that affect therapeutic success when dipeptidyl peptidase-4 (DPP-4) inhibitor is added to metformin monotherapy. Materials and Methods. We reviewed the medical records of 56 patients who had received DPP-4 inhibitor as an add-on to metformin monothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Demir, Sevin, Temizkan, Sule, Sargin, Mehmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110881/
https://www.ncbi.nlm.nih.gov/pubmed/27882332
http://dx.doi.org/10.1155/2016/4509603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110881/
https://www.ncbi.nlm.nih.gov/pubmed/27882332
http://dx.doi.org/10.1155/2016/4509603

Ejemplares similares